Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 113
Filter
1.
J Surg Res ; 257: 56-68, 2021 01.
Article in English | MEDLINE | ID: mdl-32818785

ABSTRACT

BACKGROUND: Burn injuries (BIs) due to scalding are one of the most common accidents among children. BIs greater than 40% of total body surface area are considered extensive and result in local and systemic response. We sought to assess morphological and myogenic mechanisms through both short- and long-term intensive insulin therapies that affect the skeletal muscle after extensive skin BI in young rats. MATERIALS AND METHODS: Wistar rats aged 21 d were distributed into four groups: control (C), control with insulin (C + I), scald burn injury (SI), and SI with insulin (SI + I). The SI groups were submitted to a 45% total body surface area burn, and the C + I and SI + I groups received insulin (5 UI/Kg/d) for 4 or 14 d. Glucose tolerance and the homeostatic model assessment of insulin resistance index were determined. Gastrocnemius muscles were analyzed for histopathological, morphometric, and immunohistochemical myogenic parameters (Pax7, MyoD, and MyoG); in addition, the expression of genes related to muscle atrophy (MuRF1 and MAFbx) and its regulation (IGF-1) were also assessed. RESULTS: Short-term treatment with insulin favored muscle regeneration by primary myogenesis and decreased muscle atrophy in animals with BIs, whereas the long-term treatment modulated myogenesis by increasing the MyoD protein. Both treatments improved histopathological parameters and secondary myogenesis by increasing the MyoG protein. CONCLUSIONS: Treatment with insulin benefits myogenic parameters during regeneration and modulates MuRF1, an important mediator of muscle atrophy.


Subject(s)
Burns/complications , Insulin/administration & dosage , Muscle Development/drug effects , Muscular Atrophy/prevention & control , Animals , Blood Glucose/analysis , Body Surface Area , Burns/pathology , Burns/physiopathology , Gene Expression/drug effects , Insulin-Like Growth Factor I/genetics , Male , Muscle Proteins/genetics , Muscle, Skeletal/chemistry , Muscle, Skeletal/pathology , Muscle, Skeletal/physiopathology , Muscular Atrophy/etiology , Muscular Atrophy/genetics , MyoD Protein/analysis , Myogenin/analysis , Paired Box Transcription Factors/analysis , Rats , Rats, Wistar , SKP Cullin F-Box Protein Ligases/genetics , Tripartite Motif Proteins/genetics , Ubiquitin-Protein Ligases/genetics
2.
PLoS One ; 15(7): e0234792, 2020.
Article in English | MEDLINE | ID: mdl-32614850

ABSTRACT

The Myo/Nog cell lineage was discovered in the chick embryo and is also present in adult mammalian tissues. The cells are named for their expression of mRNA for the skeletal muscle specific transcription factor MyoD and bone morphogenetic protein inhibitor Noggin. A third marker for Myo/Nog cells is the cell surface molecule recognized by the G8 monoclonal antibody (mAb). G8 has been used to detect, track, isolate and kill Myo/Nog cells. In this study, we screened a membrane proteome array for the target of the G8 mAb. The array consisted of >5,000 molecules, each synthesized in their native confirmation with appropriate post-translational modifications in a single clone of HEK-293T cells. G8 mAb binding to the clone expressing brain-specific angiogenesis inhibitor 1 (BAI1) was detected by flow cytometry, re-verified by sequencing and validated by transfection with the plasmid construct for BAI1. Further validation of the G8 target was provided by enzyme-linked immunosorbent assay. The G8 epitope was identified by screening a high-throughput, site directed mutagenesis library designed to cover 95-100% of the 954 amino acids of the extracellular domain of the BAI1 protein. The G8 mAb binds within the third thrombospondin repeat of the extracellular domain of human BAI1. Immunofluorescence localization experiments revealed that G8 and a commercially available BAI1 mAb co-localize to the subpopulation of Myo/Nog cells in the skin, eyes and brain. Expression of the multi-functional BAI1 protein in Myo/Nog cells introduces new possibilities for the roles of Myo/Nog cells in normal and diseased tissues.


Subject(s)
Angiogenic Proteins/biosynthesis , Myofibroblasts/metabolism , Receptors, G-Protein-Coupled/biosynthesis , Amino Acid Substitution , Angiogenic Proteins/chemistry , Angiogenic Proteins/genetics , Angiogenic Proteins/immunology , Animals , Antibodies, Monoclonal/immunology , Antibody Specificity , Antigen-Antibody Reactions , Brain/cytology , Carrier Proteins/analysis , Cell Lineage , Epitopes/immunology , Eye Proteins/biosynthesis , Eye Proteins/chemistry , Eye Proteins/genetics , Eye Proteins/immunology , Humans , Male , Mice , Mice, Inbred C57BL , Models, Molecular , Muscle Development , MyoD Protein/analysis , Organ Specificity , Protein Conformation , Protein Domains , Rabbits , Rats, Sprague-Dawley , Receptors, G-Protein-Coupled/chemistry , Receptors, G-Protein-Coupled/genetics , Receptors, G-Protein-Coupled/immunology , Repetitive Sequences, Amino Acid , Skin/cytology , Species Specificity , Tattooing , Young Adult
3.
Hum Pathol ; 99: 75-79, 2020 05.
Article in English | MEDLINE | ID: mdl-32217091

ABSTRACT

Fibroepithelial stromal polyps (FESPs) are benign polypoid mesenchymal lesions thought to arise from desmin-positive specialized stromal cells of the female genital tract. Although most cases are easily diagnosed by morphology alone, the morphology of FESPs is variable and in some instances can contain hypercellular stroma with numerous atypical desmin-positive cells, simulating botryoid embryonal rhabdomyosarcoma (ERMS). Recently, we encountered a cellular FESP showing desmin expression as well as nuclear immunoreactivity for the skeletal muscle-associated transcription factor MyoD1. Although these lesions are widely known to express desmin, there are very few studies examining expression of the more specific markers of skeletal muscle differentiation, myogenin and MyoD1. The aim of our study was to examine desmin, MyoD1, and myogenin expression in a series of 25 FESPs. Of the 25 cases, desmin expression was present in 23 (92%), at least focal MyoD1 expression was present in 10 (40%), and all cases were negative for myogenin. Follow-up data were available for all 25 cases, and none recurred or behaved in a malignant fashion. Awareness of this potential immunohistochemical pitfall and careful morphologic evaluation should allow for the confident distinction of MyoD1-positive FESP from botyroid ERMS in almost all instances.


Subject(s)
Biomarkers, Tumor/analysis , MyoD Protein/analysis , Neoplasms, Fibroepithelial/chemistry , Polyps/chemistry , Stromal Cells/chemistry , Vaginal Neoplasms/chemistry , Vulvar Neoplasms/chemistry , Adult , Aged , Aged, 80 and over , Diagnosis, Differential , Female , Humans , Immunohistochemistry , Middle Aged , Neoplasms, Fibroepithelial/pathology , Polyps/pathology , Predictive Value of Tests , Prognosis , Stromal Cells/pathology , Vaginal Neoplasms/pathology , Vulvar Neoplasms/pathology
4.
Urology ; 137: 173-177, 2020 03.
Article in English | MEDLINE | ID: mdl-31945380

ABSTRACT

Rhabdomyosarcoma is the most common sarcoma diagnosed in childhood and adolescence, arising from the bladder/prostate in only 5%-10% of cases. Treatment-induced cytodifferention of tumor cells into mature rhabdomyoblasts has been reported following chemoradiation and is thought to suggest a more favorable outcome. We report a case of embryonal rhabdomyosarcoma of the bladder/prostate that exhibited extensive cytodifferentiation with downregulation of myogenin and MyoD1 gene expression in rhabdomyoblasts following treatment with chemoradiation therapy. The downregulation of myogenin and MyoD1 expression in rhabdomyoblasts following chemoradiation treatment has not previously been described in the literature and its significant remains uncertain.


Subject(s)
Cell Differentiation , Chemoradiotherapy , MyoD Protein/genetics , Myogenin/genetics , Prostatic Neoplasms , Rhabdomyosarcoma, Embryonal , Urinary Bladder Neoplasms , Biomarkers, Tumor/analysis , Biomarkers, Tumor/genetics , Biopsy/methods , Cell Differentiation/drug effects , Cell Differentiation/radiation effects , Chemoradiotherapy/adverse effects , Chemoradiotherapy/methods , Diagnosis, Differential , Down-Regulation , Gene Expression , Humans , Immunohistochemistry , Infant , Male , MyoD Protein/analysis , Myogenin/analysis , Patient Selection , Prognosis , Prostatic Neoplasms/diagnostic imaging , Prostatic Neoplasms/genetics , Prostatic Neoplasms/pathology , Prostatic Neoplasms/therapy , Rhabdomyosarcoma, Embryonal/diagnostic imaging , Rhabdomyosarcoma, Embryonal/genetics , Rhabdomyosarcoma, Embryonal/pathology , Rhabdomyosarcoma, Embryonal/therapy , Urinary Bladder Neoplasms/diagnostic imaging , Urinary Bladder Neoplasms/genetics , Urinary Bladder Neoplasms/pathology , Urinary Bladder Neoplasms/therapy
5.
Am J Surg Pathol ; 43(6): 747-754, 2019 06.
Article in English | MEDLINE | ID: mdl-30829729

ABSTRACT

Biphenotypic sinonasal sarcoma (BSNS) is a locally aggressive tumor occurring in the sinonasal region. It harbors both myogenic and neural differentiation and is characterized by PAX3 rearrangement with MAML3 as the most frequent fusion partner, but the partner of PAX3 remains unidentified in a subset of cases. About 70 cases have been reported so far. In this study, we report a series of 41 cases with clinical, pathologic, and molecular description. Twenty-five (61%) patients were female individuals, and the median age was 49 years. Tumors arose predominantly in the nasal cavity and ethmoidal sinuses. Local recurrences occurred in 8 cases of the 25 (32%). Histologic features were characteristic of BSNS, with 5 cases showing focal rhabdomyoblastic differentiation. Immunohistochemistry showed a constant positivity of S100 protein and PAX3 and negativity of SOX10. MyoD1 was focally positive in 91% of cases, whereas only 20% were positive for myogenin. Molecular analysis showed a PAX3-MAML3 transcript in 37 cases (90%). RNA sequencing was performed in the 4 negative cases for PAX3-MAML3 fusion, and it showed that 1 case harbored a PAX3-FOXO1 fusion, as previously described in the literature, and 2 novel fusions: PAX3-WWTR1 fusion in 2 cases and PAX3-NCOA2 fusion in 1 case. RNA sequencing results were confirmed by fluorescence in situ hybridization, reverse transcription-polymerase chain reaction, and Sanger sequencing. The PAX3-NCOA2-positive case showed focal rhabdomyoblastic differentiation. In conclusion, we report 2 novel fusions (PAX3-WWTR1 and PAX3-NCOA2) in BSNS and show that MyoD1 is more sensitive than myogenin for demonstrating myogenic differentiation in this tumor.


Subject(s)
Biomarkers, Tumor , Nasal Cavity , Paranasal Sinus Neoplasms , Paranasal Sinuses , Sarcoma , Adult , Aged , Aged, 80 and over , Biomarkers, Tumor/analysis , Biomarkers, Tumor/genetics , Cell Differentiation , Female , Gene Fusion , Genetic Predisposition to Disease , Humans , Immunohistochemistry , In Situ Hybridization, Fluorescence , Male , Middle Aged , MyoD Protein/analysis , Nasal Cavity/chemistry , Nasal Cavity/pathology , Nuclear Receptor Coactivator 2/genetics , Oncogene Proteins, Fusion/genetics , PAX3 Transcription Factor/genetics , Paired Box Transcription Factors/genetics , Paranasal Sinus Neoplasms/chemistry , Paranasal Sinus Neoplasms/genetics , Paranasal Sinus Neoplasms/pathology , Paranasal Sinus Neoplasms/therapy , Paranasal Sinuses/chemistry , Paranasal Sinuses/pathology , Phenotype , Prospective Studies , Retrospective Studies , Sarcoma/chemistry , Sarcoma/genetics , Sarcoma/pathology , Sarcoma/therapy , Trans-Activators/genetics , Transcriptional Coactivator with PDZ-Binding Motif Proteins
6.
Methods Mol Biol ; 1732: 539-549, 2018.
Article in English | MEDLINE | ID: mdl-29480498

ABSTRACT

In this chapter, we describe the methods to isolate and culture muscle stem cells (MuSCs) from murine skeletal muscle in order to decipher the intrinsic effect of AMP-activated kinase activity on MuSC fate. Culture of MuSCs is a powerful model to recapitulate every step of stem cell behavior observed in vivo: activation, proliferation, differentiation, fusion and also self-renewal. We provide the detailed procedures to isolate pure MuSCs by a flow cytometry-based method using the selection of a combination of specific markers and to characterize MuSC fate (quiescence, activation, and differentiation) in response to AMPK activity modulation by assessing of the expression of stem cell (e.g., Pax7) and myogenic marker (e.g., MyoD).


Subject(s)
AMP-Activated Protein Kinases/metabolism , Enzyme Activation/physiology , Muscle Development/physiology , Myoblasts/physiology , Animals , Biomarkers/analysis , Biomarkers/metabolism , Cell Differentiation/physiology , Cell Separation/instrumentation , Cell Separation/methods , Cells, Cultured , Enzyme Activation/drug effects , Enzyme Activators/pharmacology , Enzyme Inhibitors/pharmacology , Flow Cytometry/instrumentation , Flow Cytometry/methods , Ki-67 Antigen/analysis , Ki-67 Antigen/metabolism , Mice , Muscle Development/drug effects , Muscle, Skeletal/cytology , MyoD Protein/analysis , MyoD Protein/metabolism , PAX7 Transcription Factor/analysis , PAX7 Transcription Factor/metabolism , Primary Cell Culture/instrumentation , Primary Cell Culture/methods
7.
J Orthop Res ; 36(5): 1370-1376, 2018 05.
Article in English | MEDLINE | ID: mdl-28786534

ABSTRACT

Rotator cuff (RC) tears are frequently complicated by muscle atrophy. Muscle stem cells (MuSCs) repair damaged myofibers following injury, but their role in the prevention or pathogenesis of atrophy following RC tears remains undefined. We hypothesized that the RC MuSC population would be affected by supraspinatus (SS) and infraspinatus (IS) tendon transection (TT) compared to uninjured muscle in a mouse model of RC tear. C57BL6/J mice underwent unilateral SS and IS TT and contralateral sham surgery. At 3, 8, or 14 weeks after injury, mice were euthanized, and SS and IS were harvested for FACS sorting of CD31-/CD45-/Sca1-/ITGa7+/VCAM+ MuSCs or histological analysis. Ki-67+ MuSCs from injured muscle increased 3.4-fold at 3 weeks (p = 0.03) and 8.1-fold at 8 weeks (p = 0.04) following TT injury, but returned to baseline by 14 weeks (p = 0.91). Myod1 remained upregulated 3.3-fold at 3 weeks (p = 0.03) and 2.0-fold at 14 weeks (p = 0.0003), respectively. Myofiber cross-sectional area was decreased at both 3 and 14 weeks after injury, but the number of MuSCs per fiber remained relatively constant at 3 (p = 0.3) and 14 (p = 0.6) weeks after TT. In this study, we characterized the longitudinal effect of RC tendon injury on the MuSC population in supraspinatus and infraspinatus muscles. MuSCs are transiently activated, and are not depleted, in spite of persistent muscle atrophy. © 2017 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 36:1370-1376, 2018.


Subject(s)
Rotator Cuff Injuries/pathology , Satellite Cells, Skeletal Muscle/physiology , Animals , Cell Cycle , Female , Mice , Mice, Inbred C57BL , Muscular Atrophy/pathology , MyoD Protein/analysis
8.
J Vis Exp ; (111)2016 05 17.
Article in English | MEDLINE | ID: mdl-27286495

ABSTRACT

Skeletal muscle terminal differentiation starts with the commitment of pluripotent mesodermal precursor cells to myoblasts. These cells have still the ability to proliferate or they can differentiate and fuse into multinucleated myotubes, which maturate further to form myofibers. Skeletal muscle terminal differentiation is orchestrated by the coordinated action of various transcription factors, in particular the members of the Muscle Regulatory Factors or MRFs (MyoD, Myogenin, Myf5, and MRF4), also called the myogenic bHLH transcription factors family. These factors cooperate with chromatin-remodeling complexes within elaborate transcriptional regulatory network to achieve skeletal myogenesis. In this, MyoD is considered the master myogenic transcription factor in triggering muscle terminal differentiation. This notion is strengthened by the ability of MyoD to convert non-muscle cells into skeletal muscle cells. Here we describe an approach used to identify MyoD protein partners in an exhaustive manner in order to elucidate the different factors involved in skeletal muscle terminal differentiation. The long-term aim is to understand the epigenetic mechanisms involved in the regulation of skeletal muscle genes, i.e., MyoD targets. MyoD partners are identified by using Tandem Affinity Purification (TAP-Tag) from a heterologous system coupled to mass spectrometry (MS) characterization, followed by validation of the role of relevant partners during skeletal muscle terminal differentiation. Aberrant forms of myogenic factors, or their aberrant regulation, are associated with a number of muscle disorders: congenital myasthenia, myotonic dystrophy, rhabdomyosarcoma and defects in muscle regeneration. As such, myogenic factors provide a pool of potential therapeutic targets in muscle disorders, both with regard to mechanisms that cause disease itself and regenerative mechanisms that can improve disease treatment. Thus, the detailed understanding of the intermolecular interactions and the genetic programs controlled by the myogenic factors is essential for the rational design of efficient therapies.


Subject(s)
Mass Spectrometry , Muscle, Skeletal/metabolism , MyoD Protein/analysis , Cell Differentiation , Humans , Muscle, Skeletal/cytology , Myogenin , Transcription Factors
9.
Int J Exp Pathol ; 96(5): 285-93, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26515458

ABSTRACT

In Duchenne muscular dystrophy (DMD), the search for new biomarkers to follow the evolution of the disease is of fundamental importance in the light of the evolving gene and pharmacological therapies. In addition to the lack of dystrophin, secondary events including changes in calcium levels, inflammation and fibrosis greatly contribute to DMD progression and the molecules involved in these events may represent potential biomarkers. In this study, we performed a comparative evaluation of the progression of dystrophy within muscles that are differently affected by dystrophy (diaphragm; DIA and quadriceps; QDR) or spared (intrinsic laryngeal muscles) using the mdx mice model of DMD. We assessed muscle levels of calsequestrin (calcium-related protein), tumour necrosis factor (TNF-α; pro-inflammatory cytokine), tumour growth factor (TGF-ß; pro-fibrotic factor) and MyoD (muscle proliferation) vs. histopathology at early (1 and 4 months of age) and late (9 months of age) stages of dystrophy. Fibrosis was the primary feature in the DIA of mdx mice (9 months: 32% fibrosis), which was greater than in the QDR (9 months: 0.6% fibrosis). Muscle regeneration was the primary feature in the QDR (9 months: 90% of centrally nucleated fibres areas vs. 33% in the DIA). The QDR expressed higher levels of calsequestrin than the DIA. Laryngeal muscles showed normal levels of TNF-α, TGF-ß and MyoD. A positive correlation between histopathology and cytokine levels was observed only in the diaphragm, suggesting that TNF-α and TGF-ß serve as markers of dystrophy primarily for the diaphragm.


Subject(s)
Biomarkers/analysis , Diaphragm/metabolism , Laryngeal Muscles/metabolism , Muscular Dystrophy, Duchenne/metabolism , Quadriceps Muscle/metabolism , Animals , Blotting, Western , Calsequestrin/analysis , Calsequestrin/biosynthesis , Diaphragm/pathology , Disease Models, Animal , Disease Progression , Female , Fluorescent Antibody Technique , Laryngeal Muscles/pathology , Male , Mice , Mice, Inbred mdx , MyoD Protein/analysis , MyoD Protein/biosynthesis , Quadriceps Muscle/pathology , Transforming Growth Factor beta/analysis , Transforming Growth Factor beta/biosynthesis , Tumor Necrosis Factor-alpha/analysis , Tumor Necrosis Factor-alpha/biosynthesis
10.
Acta Cir Bras ; 30(2): 94-9, 2015 Feb.
Article in English | MEDLINE | ID: mdl-25714687

ABSTRACT

PURPOSE: To investigate the effectiveness of low-level laser therapy (LLLT) on gastrocnemius muscle morphology and Myod immunoexpression in a model of dorsal burn in rats. METHODS: Sixteen male Wistar rats were distributed into two groups: control group (CG): rats submitted to scald burn injury without treatment and laser treated group (LG): rats submitted to scald burn injury and treated with laser therapy. Fourteen days post-surgery, gastrocnemius muscle was evaluated being the specimens stained with HE and morphometric data was evaluated. MyoD expression was assessed by immunohistochemistry. RESULTS: The results showed that laser treated animals presented more organized tissue morphology compared to the non-treated animals, with a higher number of nucleus in the fibers. Also, the cross sectional area of the fibers and the MyoD immunoexpression in the laser treated groups was higher. CONCLUSION: Low-level laser therapy had positive effects on gastrocnemius muscle, improving tissue muscle morphology, increasing cross sectional area and MyoD immunoexpression.


Subject(s)
Burns/radiotherapy , Low-Level Light Therapy/methods , Muscle, Skeletal/radiation effects , MyoD Protein/analysis , Animals , Burns/metabolism , Burns/pathology , Cell Count , Disease Models, Animal , Immunohistochemistry , Male , Muscle Fibers, Skeletal/radiation effects , Muscle, Skeletal/pathology , MyoD Protein/radiation effects , Rats, Wistar , Reproducibility of Results , Skin/injuries , Skin/radiation effects , Time Factors , Treatment Outcome
11.
Acta cir. bras ; 30(2): 94-99, 02/2015. graf
Article in English | LILACS | ID: lil-741029

ABSTRACT

PURPOSE: To investigate the effectiveness of low-level laser therapy (LLLT) on gastrocnemius muscle morphology and Myod imunoexpression in a model of dorsal burn in rats. METHODS: Sixteen male Wistar rats were distributed into two groups: control group (CG): rats submitted to scald burn injury without treatment and laser treated group (LG): rats submitted to scald burn injury and treated with laser therapy. Fourteen days post-surgery, gastrocnemius muscle was evaluated being the specimens stained with HE and morphometric data was evaluated. MyoD expression was assessed by immunohistochemistry. RESULTS: The results showed that laser treated animals presented more organized tissue morphology compared to the non-treated animals, with a higher number of nucleus in the fibers. Also, the cross sectional area of the fibers and the MyoD immunoexpression in the laser treated groups was higher. CONCLUSION: Low-level laser therapy had positive effects on gastrocnemius muscle, improving tissue muscle morphology, increasing cross sectional area and MyoD immunoexpression. .


Subject(s)
Animals , Male , Burns/radiotherapy , Low-Level Light Therapy/methods , Muscle, Skeletal/radiation effects , MyoD Protein/analysis , Burns/metabolism , Burns/pathology , Cell Count , Disease Models, Animal , Immunohistochemistry , Muscle Fibers, Skeletal/radiation effects , Muscle, Skeletal/pathology , MyoD Protein/radiation effects , Rats, Wistar , Reproducibility of Results , Skin/injuries , Skin/radiation effects , Time Factors , Treatment Outcome
12.
Pediatr Blood Cancer ; 62(6): 1011-6, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25557260

ABSTRACT

BACKGROUND: Clinical characteristics and optimal treatment strategies for spindle cell/sclerosing rhabdomyosarcoma (ssRMS) have not been well established because of its rarity. PROCEDURE: Retrospective re-evaluation of sarcoma specimens (1997-2014) identified 16 ssRMSs (median age 20 years, range 7-39 years). Clinicopathological features, clinical course, and outcome were analyzed. RESULTS: Primary disease sites were the head and neck (10 cases) and other regions (6 cases). Nine cases were at Intergroup Rhabdomyosarcoma Study preoperative stage 3. The primary tumors were >5 cm in 13 cases. Two patients had lymph node metastases, but none had distant metastases at presentation. At follow-up (median period 39 months, range 4.6-201), seven patients were alive without disease. Among nine patients treated with the vincristine, actinomycin, and cyclophosphamide (VAC) regimen, five responded well, with four surviving free of disease. Among ten patients with recurrent or progressive disease, three experienced local recurrence, four had distant metastases, and three had both. None exhibited bone marrow invasion. Eight of the ten patients died in median time from relapse to death of 18 months (range 11-56). CONCLUSIONS: Although most ssRMSs present as a bulky tumor, nodal or distant metastases are rare at presentation. ssRMSs initially show good response to VAC, but >50% of tumors recur or progress; these data suggest a worse prognosis of ssRMS compared to the pediatric embryonal variant. As relapse typically occurs as local or distant solitary lesion without bone marrow invasion, localized treatment combined with chemotherapy would contribute to improve the prognosis of recurrent ssRMS.


Subject(s)
Rhabdomyosarcoma/pathology , Adolescent , Adult , Child , Female , Humans , Male , MyoD Protein/analysis , Retrospective Studies , Rhabdomyosarcoma/chemistry , Rhabdomyosarcoma/therapy
13.
J Dent Res ; 94(3): 421-9, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25576472

ABSTRACT

The tongue is a muscular organ that is essential in vertebrates for important functions, such as food intake and communication. Little is known about regulation of myogenic progenitors during tongue development when compared with the limb or trunk region. In this study, we investigated the relationship between different myogenic subpopulations and the function of canonical Wnt signaling in regulating these subpopulations. We found that Myf5- and MyoD-expressing myogenic subpopulations exist during embryonic tongue myogenesis. In the Myf5-expressing myogenic progenitors, there is a cell-autonomous requirement for canonical Wnt signaling for cell migration and differentiation. In contrast, the MyoD-expressing subpopulation does not require canonical Wnt signaling during tongue myogenesis. Taken together, our results demonstrate that canonical Wnt signaling differentially regulates the Myf5- and MyoD-expressing subpopulations during tongue myogenesis.


Subject(s)
Muscle Development/physiology , Stem Cells/physiology , Tongue/embryology , Wnt Signaling Pathway/physiology , Animals , Axin Protein/analysis , Axin Protein/physiology , Cell Differentiation/physiology , Cell Lineage/physiology , Cell Movement/physiology , Mice , Muscle Fibers, Skeletal/cytology , MyoD Protein/analysis , MyoD Protein/physiology , Myogenic Regulatory Factor 5/analysis , Myogenic Regulatory Factor 5/physiology , RNA, Untranslated/analysis , RNA, Untranslated/physiology , Tongue/cytology , beta Catenin/analysis , beta Catenin/physiology
14.
J Oral Maxillofac Surg ; 72(9): 1773-87, 2014 Sep.
Article in English | MEDLINE | ID: mdl-24602810

ABSTRACT

PURPOSE: To document the bone formation and soft tissue changes in response to automated, continuous, curvilinear distraction osteogenesis (DO) at rates greater than 1 mm/day in a minipig model. MATERIALS AND METHODS: Two groups of Yucatan minipigs underwent automated, continuous, curvilinear DO of the right mandible: group A, 1.5 mm/day (n = 5); and group B, 3.0 mm/day (n = 5). Each minipig underwent 12 mm of distraction followed by 24 days of fixation. The distracted and contralateral mandibles were harvested at the end of fixation. The percentage of surface area (PSA) of the regenerate occupied by bone, fibrous tissue, cartilage, and hematoma was determined using computerized histomorphometric analysis. The control groups consisted of DO wounds distracted discontinuously at 1 mm/day and the nonoperated contralateral mandible. The ipsilateral and contralateral digastric muscles were harvested and stained for proliferating cell nuclear antigen (PCNA), myogenic differentiation-1 (MyoD), and paired Box 7 protein (PAX7). RESULTS: All 10 minipigs completed the distraction and fixation period. The PSA occupied by bone was similar for groups A (PSA 64.36% ± 5.87%) and B (PSA 63.83% ± 3.37%) and the control group (1 mm/day; PSA 64.89% ± 0.56%) but was less than that on the nonoperated side (PSA 84.67% ± 0.86%). The PSA occupied by cartilage and hematoma in all groups was minimal (<1.1%). The digastric muscles had no abnormal tissue or inflammation, and PAX7, MyoD, and PCNA expression had returned to the baseline levels. CONCLUSIONS: The results of the present study indicate that bone formation in response to automated, continuous, and curvilinear DO at a rate of 1.5 and 3.0 mm/day is nearly identical to that with discontinuous DO at 1 mm/day. In addition, no deleterious effects were found on the digastric muscles.


Subject(s)
Mandible/surgery , Neck Muscles/pathology , Osteogenesis, Distraction/methods , Animals , Bone Density/physiology , Bone Regeneration/physiology , Cartilage/pathology , Connective Tissue/pathology , Female , Hematoma/pathology , Image Processing, Computer-Assisted/methods , Mandible/pathology , Models, Animal , MyoD Protein/analysis , Osteogenesis/physiology , PAX7 Transcription Factor/analysis , Proliferating Cell Nuclear Antigen/analysis , Swine , Swine, Miniature , Time Factors
15.
Surg Today ; 44(2): 378-82, 2014 Feb.
Article in English | MEDLINE | ID: mdl-23184358

ABSTRACT

This report presents a case of primary pleomorphic rhabdomyosarcoma arising in the duodenum. A 63-year-old male with persistent melena was referred for a solid tumor in his right upper abdomen detected using ultrasonography. Gastrofiberscopy revealed a protrusion in the upper part of the duodenum, with a large ulcer on the top of it. Enhanced computed tomography showed that the tumor extended to the pancreas. Pancreaticoduodenectomy was performed, despite the absence of malignant cells in the biopsy specimen, with a preoperative diagnosis of duodenal cancer. The tumor consisted of multiple cell types, and immunohistochemical staining was positive for desmin, HHF-35 and alpha smooth muscle actin. Electron microscopy revealed primitive Z-band structures in the tumor. The final diagnosis was pleomorphic rhabdomyosarcoma of the duodenum. This is the first report of primary rhabdomyosarcoma occurring in the duodenum, confirmed by immunohistochemical staining and electron microscopy.


Subject(s)
Duodenal Neoplasms/diagnosis , Duodenal Neoplasms/surgery , Rhabdomyosarcoma/diagnosis , Rhabdomyosarcoma/surgery , Biomarkers, Tumor/analysis , Desmin/analysis , Duodenal Neoplasms/pathology , Duodenal Neoplasms/ultrastructure , Humans , Immunohistochemistry , Male , Middle Aged , MyoD Protein/analysis , Pancreaticoduodenectomy , Rhabdomyosarcoma/pathology , Rhabdomyosarcoma/ultrastructure , Treatment Outcome
16.
J Rehabil Res Dev ; 50(7): 985-96, 2013.
Article in English | MEDLINE | ID: mdl-24301435

ABSTRACT

The aim of this study was to evaluate the effects of 660 nm low-level laser therapy (LLLT) on muscle regeneration after cryolesion in rat tibialis anterior muscle. Sixty-three Wistar rats were divided into a control group, 10 J/cm(2) laser-treated group, and 50 J/cm(2) laser-treated group. Each group formed three subgroups (n = 7 per group), and the animals were sacrificed 7, 14, or 21 d after lesion. Histopathological findings revealed a lower inflammatory process in the laser-treated groups after 7 d. After 14 d, irradiated animals at both fluences showed higher granulation tissue, new muscle fibers, and organized muscle structure. After 21 d, full tissue repair was observed in all groups. Moreover, irradiated animals at both fluences showed smaller necrosis area in the first experimental period evaluated. MyoD immunoexpression was observed in both treated groups 7 d postinjury. Myogenin immunoexpression was detected after 7 and 14 d. The higher fluence increased the number of blood vessels after 14 and 21 d. These results suggest that LLLT, at both fluences, positively affects injured skeletal muscle in rats, accelerating the muscle-regeneration process.


Subject(s)
Lasers, Semiconductor/therapeutic use , Low-Level Light Therapy , Muscle, Skeletal/physiology , Wound Healing/radiation effects , Animals , Cold Temperature , Granulation Tissue/pathology , Inflammation/pathology , Male , Muscle, Skeletal/injuries , MyoD Protein/analysis , Myogenin/analysis , Rats , Rats, Wistar
17.
Exp Biol Med (Maywood) ; 238(12): 1421-30, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24186267

ABSTRACT

The mechanisms of muscle wasting and decreased mobility have a major functional effect in rheumatoid arthritis, but they have been poorly studied. The objective of our study is to describe muscular involvement and the pathways in an experimental model of arthritis compared to the pathways in disuse atrophy. Female Wistar rats were separated into three groups: control (CO), collagen-induced arthritis (CIA), and immobilized (IM). Spontaneous locomotion and weight were evaluated weekly. The gastrocnemius muscle was evaluated by histology and immunoblotting to measure the expression of myostatin (a negative regulator), LC3 (autophagy), MuRF-1 (proteasome-mediated proteolysis), MyoD, and myogenin (satellite-cell activation). The significance level was set at P < 0.05, and histological analysis of joints confirmed the severity of the arthropathy. There was a significant difference in spontaneous locomotion in the CIA group. Animal body weight, gastrocnemius muscle weight, and relative muscle weight decreased 20%, 30%, and 20%, respectively, in the CIA rats. Inflammatory infiltration and swelling were present in the gastrocnemius muscles of the CIA rats. The mean cross-sectional area was reduced by 30% in the CIA group and by 60% in the IM group. The expressions of myostatin and LC3 between the groups were similar. There was increased expression of MuRF-1 in the IM (1.9-fold) and CIA (3.1-fold) groups and of myogenin in the muscles of the CIA animals (1.7-fold), while MyoD expression was decreased in the IM (20%) rats. This study demonstrated that the development of experimental arthritis is associated with decreased mobility, body weight, and muscle loss. Both IM and CIA animal models presented muscle atrophy, but while proteolysis and the regeneration pathways were activated in the CIA model, there was no activation of regeneration in the IM model. We can assume that muscle atrophy in experimental arthritis is associated with the disease itself and not simply with decreased mobility.


Subject(s)
Arthritis/complications , Muscles/pathology , Muscular Atrophy/etiology , Animals , Arthritis/chemically induced , Arthritis/physiopathology , Collagen/pharmacology , Disease Models, Animal , Female , Microtubule-Associated Proteins/analysis , Muscle Proteins/analysis , Muscles/chemistry , Muscles/physiopathology , Muscular Atrophy/pathology , Muscular Atrophy/physiopathology , MyoD Protein/analysis , Myogenin/analysis , Myostatin/analysis , Rats , Rats, Wistar , Restraint, Physical/adverse effects , Tripartite Motif Proteins , Ubiquitin-Protein Ligases/analysis
18.
Nucleic Acids Res ; 41(11): 5704-16, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23609547

ABSTRACT

The regulation of skeletal muscle gene expression during myogenesis is mediated by lineage-specific transcription factors in combination with numerous cofactors, many of which modify chromatin structure. However, the involvement of scaffolding proteins that organize chromatin and chromatin-associated regulatory proteins has not extensively been explored in myogenic differentiation. Here, we report that Scaffold attachment factor b1 (Safb1), primarily associated with transcriptional repression, functions as a positive regulator of myogenic differentiation. Knockdown of Safb1 inhibited skeletal muscle marker gene expression and differentiation in cultured C2C12 myoblasts. In contrast, over-expression resulted in the premature expression of critical muscle structural proteins and formation of enlarged thickened myotubes. Safb1 co-immunoprecipitated with MyoD and was co-localized on myogenic promoters. Upon Safb1 knockdown, the repressive H3K27me3 histone mark and binding of the Polycomb histone methyltransferase Ezh2 persisted at differentiation-dependent gene promoters. In contrast, the appearance of histone marks and regulators associated with myogenic gene activation, such as myogenin and the SWI/SNF chromatin remodelling enzyme ATPase, Brg1, was blocked. These results indicate that the scaffold protein Safb1 contributes to the activation of skeletal muscle gene expression during myogenic differentiation by facilitating the transition of promoter sequences from a repressive chromatin structure to one that is transcriptionally permissive.


Subject(s)
Chromatin/metabolism , DNA-Binding Proteins/physiology , Muscle Development/genetics , Muscle, Skeletal/metabolism , RNA-Binding Proteins/physiology , Transcriptional Activation , Animals , Cell Line , DNA-Binding Proteins/analysis , Gene Expression , Mice , MyoD Protein/analysis , Myoblasts, Skeletal/cytology , Myoblasts, Skeletal/metabolism , Polycomb-Group Proteins/metabolism , Promoter Regions, Genetic , RNA-Binding Proteins/analysis
19.
J Endod ; 39(1): 68-75, 2013 Jan.
Article in English | MEDLINE | ID: mdl-23228260

ABSTRACT

INTRODUCTION: The purpose of this study was to examine the effect of mineral trioxide aggregate (MTA) on pluripotent-mesenchymal cell differentiation. METHODS: The pluripotent-mesenchymal cell line C2C12 was cultured in a 5% serum medium to induce cell differentiation with or without MTA. The differentiation to myoblasts was analyzed by the immunocytochemical staining of myosin heavy chains. The cellular phenotype-specific markers characterizing the osteoblasts (Runx2 and osterix), chondroblasts (Sox9), myoblasts (MyoD), and adipocytes (LPL) were estimated with mRNA and protein levels by using real-time polymerase chain reaction and Western blot analysis, respectively. To verify that the effect of MTA was caused by the released calcium ions, the mRNA levels were analyzed in the presence or absence of MTA with ethylene glycol tetraacetic acid, calcium chloride, or verapamil. RESULTS: C2C12 cells cultured without MTA altered their phenotype to myoblasts, exhibiting positive reactions to myosin heavy chains. However, the cells cultured with MTA were strongly inhibited from developing into myoblasts. The mRNA and protein expressions of Runx2, osterix, and Sox9 significantly increased with MTA; the expressions of MyoD and LPL decreased significantly. Calcium chloride addition without MTA presented a significant increase of mRNA levels of Runx2, osterix, and Sox9; ethylene glycol tetraacetic acid addition with MTA presented a significant increase of mRNA levels of MyoD and LPL. Verapamil blocked the stimulating or suppressing effect of MTA on these transcription factors. CONCLUSIONS: Our study showed that MTA converted the differentiation pathway of C2C12 cells into osteoblast and/or chondroblast lineages as a result of elution components such as calcium ions from MTA.


Subject(s)
Aluminum Compounds/chemistry , Calcium Compounds/chemistry , Calcium/pharmacology , Mesenchymal Stem Cells/drug effects , Oxides/chemistry , Pluripotent Stem Cells/drug effects , Root Canal Filling Materials/chemistry , Silicates/chemistry , Adipocytes/drug effects , Calcium/chemistry , Calcium Channel Blockers/pharmacology , Calcium Chloride/pharmacology , Cell Count , Cell Culture Techniques , Cell Differentiation/drug effects , Cell Line , Cell Lineage/drug effects , Cell Proliferation/drug effects , Chelating Agents/pharmacology , Chondrocytes/drug effects , Core Binding Factor Alpha 1 Subunit/analysis , Drug Combinations , Egtazic Acid/pharmacology , Humans , Lipoprotein Lipase/analysis , Muscle Fibers, Skeletal/drug effects , MyoD Protein/analysis , Myoblasts/drug effects , Myosin Heavy Chains/analysis , Osteoblasts/drug effects , SOX9 Transcription Factor/analysis , Sp7 Transcription Factor , Transcription Factors/analysis , Verapamil/pharmacology
20.
BMC Musculoskelet Disord ; 13: 43, 2012 Mar 23.
Article in English | MEDLINE | ID: mdl-22443334

ABSTRACT

BACKGROUND: Limb girdle muscular dystrophy (LGMD) type 2A is caused by mutations in the CAPN3 gene and complete lack of functional calpain 3 leads to the most severe muscle wasting. Calpain 3 is suggested to be involved in maturation of contractile elements after muscle degeneration. The aim of this study was to investigate how mutations in the four functional domains of calpain 3 affect muscle regeneration. METHODS: We studied muscle regeneration in 22 patients with LGMD2A with calpain 3 deficiency, in five patients with LGMD2I, with a secondary reduction in calpain 3, and in five patients with Becker muscular dystrophy (BMD) with normal calpain 3 levels. Regeneration was assessed by using the developmental markers neonatal myosin heavy chain (nMHC), vimentin, MyoD and myogenin and counting internally nucleated fibers. RESULTS: We found that the recent regeneration as determined by the number of nMHC/vimentin-positive fibers was greatly diminished in severely affected LGMD2A patients compared to similarly affected patients with LGMD2I and BMD. Whorled fibers, a sign of aberrant regeneration, was highly elevated in patients with a complete lack of calpain 3 compared to patients with residual calpain 3. Regeneration is not affected by location of the mutation in the CAPN3 gene. CONCLUSIONS: Our findings suggest that calpain 3 is needed for the regenerative process probably during sarcomere remodeling as the complete lack of functional calpain 3 leads to the most severe phenotypes.


Subject(s)
Calpain/analysis , Muscle Proteins/analysis , Muscle, Skeletal/chemistry , Muscular Dystrophies, Limb-Girdle/metabolism , Muscular Dystrophy, Duchenne/metabolism , Regeneration , Adolescent , Adult , Apoptosis , Biomarkers/analysis , Biopsy , Blotting, Western , Calpain/genetics , Denmark , Dystrophin/genetics , Female , Genetic Predisposition to Disease , Humans , Immunohistochemistry , Linear Models , Male , Middle Aged , Muscle Proteins/genetics , Muscle, Skeletal/pathology , Muscle, Skeletal/physiopathology , Muscular Dystrophies, Limb-Girdle/genetics , Muscular Dystrophies, Limb-Girdle/pathology , Muscular Dystrophies, Limb-Girdle/physiopathology , Muscular Dystrophy, Duchenne/genetics , Muscular Dystrophy, Duchenne/pathology , Muscular Dystrophy, Duchenne/physiopathology , Mutation , MyoD Protein/analysis , Myogenin/analysis , Myosin Heavy Chains/analysis , Pentosyltransferases , Phenotype , Proteins/genetics , Regeneration/genetics , Severity of Illness Index , Vimentin/analysis , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...